Second US patient identified with super-resistant bacteria
A second US patient has been infected with a superbug that is highly resistant to last-resort antibiotics, scientists said Monday.
Jun 28, 2016
0
159
A second US patient has been infected with a superbug that is highly resistant to last-resort antibiotics, scientists said Monday.
Jun 28, 2016
0
159
The over-the-counter anti-inflammatory drug naproxen may also exhibit antiviral activity against influenza A virus, according to a team of French scientists. The finding, the result of a structure-based investigation, is ...
Mar 21, 2013
0
1
As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these individuals to live productive, symptom-free lives, but a cure that permanently eliminates ...
Mar 28, 2023
0
51
No vaccine or drug has yet become available against the Dengue virus. A flavivirus like the newly prominent Zika virus, Dengue has become a leading cause of serious illness and death in some Asian and Latin American countries. ...
Feb 8, 2016
0
1
Pinning down an effective way to combat the spread of the human immunodeficiency virus, the viral precursor to AIDS, has long been challenge task for scientists and physicians, because the virus is an elusive one that mutates ...
Sep 19, 2013
1
0
The number of potential therapeutic options for treatment of COVID-19 is growing. Approaches include blocking SARS-CoV-2 from entering cells, disrupting the virus' replication, antivirals, vaccines, and suppressing overactive ...
Mar 26, 2020
0
11
In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance.
May 24, 2017
0
85
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.
Apr 17, 2015
1
59
A treatment pioneered at the University of Pittsburgh Center for Vaccine Research (CVR) is far more effective than traditional antibiotics at inhibiting the growth of drug-resistant bacteria, including so-called "superbugs" ...
Dec 10, 2014
0
0
A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication.
Aug 23, 2022
0
18